Skip to main content
Premium Trial:

Request an Annual Quote

Epigenomics to Continue Cancer Biomarker Collaboration with AstraZeneca

NEW YORK, May 16 (GenomeWeb News) - Epigenomics said today that it will continue a collaboration with AstraZeneca to identify DNA methylation biomarker candidates for use in AstraZeneca's oncology programs.


Epigenomics said that it successfully completed a biomarker-discovery study with AstraZeneca last year, and that it will now test the potential of those markers to predict response to EGFR inhibitors such as AstraZeneca's Iressa in a panel of preclinical cancer models.


Under the terms of the agreement, Epigenomics will receive R&D fees and can participate in the development of any pharmacodiagnostic products resulting from the collaboration.


Further financial details were not disclosed.

The Scan

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.

Seagull Microbiome Altered by Microplastic Exposure

The overall diversity and the composition at gut microbiome sites appear to coincide with microplastic exposure and ingestion in two wild bird species, according to a new Nature Ecology and Evolution study.

Study Traces Bladder Cancer Risk Contributors in Organ Transplant Recipients

In eLife, genome and transcriptome sequencing reveal mutation signatures, recurrent somatic mutations, and risky virus sequences in bladder cancers occurring in transplant recipients.

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.